The prices of the devices marketed by 24Genetics range from approximately 99 euros to 400 euros. The company offers different DNA tests: ancestry, nutrigenetic, pharmaceutical, health,...
Initial trial results for SPVN06 are expected in 2023, with first efficacy data expected in 2025. SparingVision is also developing SPVN20, a second gene therapy drug...
CaixaResearch promotes cutting-edge research in health and biomedicine. The "la Caixa" Foundation's call for health research supports 33 projects of excellence from universities and research centers...
Each of the clinics that make up IVI RMA's worldwide network (more than 65 clinics) is likely to pursue one or more of the lines of...
GE Healthcare is divided into four areas. The first is imaging (with X-ray equipment, for example), ultrasound, patient care solutions, and pharmaceuticals. The company's annual turnover...
The Catalan pharmaceutical company Grifols reduced its profit by 46% through June, a period in which it earned €144.1 million. In 2021, the pharmaceutical company specializing...
Bayer posted a profit of €2.99 billion in the first half of 2022, compared with a loss of €246 million in the first half of last...
Novartis has the worst rating in the European pharmaceutical industry, while AstraZeneca downgrades its expectations from exceptional to neutral. Credit Suisse has also analyzed the Spanish...
Moderna considers Spain to be a key market due to its access to talent, business environment, and the quality of infrastructure, as well as the government's...
Currently, Abi Health has 25 employees and plans to expand the workforce to 60 employees once the financing round is closed, a fact expected this fall....